Literature DB >> 4155664

The treatment of arterial hypertension with a new alpha-blocker, indoramin.

R Carballo, L Conde, M Lapelle, J Suarez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4155664     DOI： 10.1185/03007997409115239

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN： 0300-7995            Impact factor:   2.580


× No keyword cloud information.
  5 in total

1.  Alpha blockers and converting enzyme inhibitors.

Authors:  P K Marrott; M Cohen
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-28

2.  Cardiovascular effects of indoramin in man--a dose ranging study.

Authors:  D P Nicholls; D W Harron; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

Review 3.  Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.

Authors:  B Holmes; E M Sorkin
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

4.  Studies on the metabolism of the new anti-hypertensive agent, indoramin, in man.

Authors:  R A Franklin; P Robson; D Stevenson
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoramin.

Authors:  V Pierce; N B Shepperson; M H Todd; J F Waterfall
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.